Works by Povala, Guilherme
Results: 73
Soluble amyloid-beta isoforms predict downstream Alzheimer's disease pathology.
- Published in:
- Cell & Bioscience, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13578-021-00712-3
- By:
- Publication type:
- Article
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2345175, doi. 10.1001/jamanetworkopen.2023.45175
- By:
- Publication type:
- Article
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease.
- Published in:
- Molecular Neurodegeneration, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13024-024-00753-5
- By:
- Publication type:
- Article
Evaluating Congruence Between Clinical and Biological Staging Across The Alzheimer's Disease Spectrum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.093241
- By:
- Publication type:
- Article
Associations between brain metabolism and financial capacity in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.093143
- By:
- Publication type:
- Article
Association between Long COVID and neuropsychological outcomes in a Brazilian Cohort: preliminary results.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.093084
- By:
- Publication type:
- Article
Hippocampal degeneration is associated with GFAP levels in individuals with vascular dementia independently of amyloidosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.092720
- By:
- Publication type:
- Article
Plasma high‐density lipoprotein levels is associated with preserved hippocampal volume in Alzheimer's disease individuals without vascular co‐pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.092693
- By:
- Publication type:
- Article
Tau exacerbates the development of distinct neuropsychiatric symptoms in late braak stage – the head study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.092310
- By:
- Publication type:
- Article
Robust Symptomatic Subtypes of Typical Alzheimer's Disease Characterized by Differential Neuropathological Patterns and Functional Decline.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.091322
- By:
- Publication type:
- Article
Attention‐deficit/hyperactivity disorder impacts the development of neuropsychiatric symptoms in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.089857
- By:
- Publication type:
- Article
ZNF653 transcription factor activity is associated with FDG‐PET changes in AD brain‐vulnerable regions.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.084700
- By:
- Publication type:
- Article
Omics‐derived biological modules reflect metabolic brain changes in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 10, p. 6709, doi. 10.1002/alz.14095
- By:
- Publication type:
- Article
A novel ultrasensitive assay for plasma p‐tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 2, p. 1239, doi. 10.1002/alz.13525
- By:
- Publication type:
- Article
Employing transfer learning to optimize deep learning models for Alzheimer's disease classification using two tau PET tracers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082824
- By:
- Publication type:
- Article
Increased Genetic Risk for ADHD Potentiates Cognitive Impairment and Brain Hypometabolism in Alzheimer's Disease Patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080519
- By:
- Publication type:
- Article
Neuroinflammation Exacerbates Irritability and Agitation in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080138
- By:
- Publication type:
- Article
Microglial Activation Contributes to Neuropsychiatric Dysfunction in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079969
- By:
- Publication type:
- Article
Microglial activation interacts with amyloid‐β to drive longitudinal tau tangle accumulation and cognitive decline.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079188
- By:
- Publication type:
- Article
Increased regional brain inflammation predicts longitudinal brain atrophy in individuals in the Alzheimer's disease continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079000
- By:
- Publication type:
- Article
Association of reactive astrogliosis and microglial activation with tau pathology in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078423
- By:
- Publication type:
- Article
Astrocyte reactivity potentiates longitudinal tau tangle accumulation in cognitively unimpaired individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078421
- By:
- Publication type:
- Article
Amyloid and Tau Predominance Subtyping Identifies CI Patients With Different Clinical Phenotypes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078343
- By:
- Publication type:
- Article
The relationship between [<sup>18</sup>F]FDG‐PET signal and key‐players of brain glucose metabolism.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080440
- By:
- Publication type:
- Article
Association between brain [<sup>18</sup>F]FDG‐PET signal and genetic cell markers in the brain tissue.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080168
- By:
- Publication type:
- Article
Potential utility of using both APOEε4 and Aβ positivity to enrich clinical trials of tau‐targeting therapies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079764
- By:
- Publication type:
- Article
APOEε4 potentiates the effects of Aβ pathology on the deposition of neurofibrillary tangles via tau phosphorylation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079681
- By:
- Publication type:
- Article
Astrocyte reactivity is associated with synaptic dysfunction across the aging and Alzheimer's disease spectrum, whereas microglial reactivity is specifically associated with synaptic dysfunction related to cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080143
- By:
- Publication type:
- Article
CSF total tau is more closely associated with synaptic dysfunction than overt neurodegeneration.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079855
- By:
- Publication type:
- Article
Synapse dysfunction and astrocyte reactivity are associated independently of amyloid‐β and tau pathologies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079816
- By:
- Publication type:
- Article
Sex impacts the association of plasma Glial Fibrillary Acidic Protein with neurodegeneration in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076402
- By:
- Publication type:
- Article
Synaptic dysfunction, Tau pathology and Neurodegeneration.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080006
- By:
- Publication type:
- Article
Plasma p‐tau and brain‐derived total tau biomarkers predict longitudinal changes in Aβ, tau, and cognition across the AD continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078070
- By:
- Publication type:
- Article
Sex modulates the role of astrocyte reactivity in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077995
- By:
- Publication type:
- Article
Plasma p‐tau181 and nfl as surrogates biomarkers in clinical trials targeting preclinical stage of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077906
- By:
- Publication type:
- Article
Amyloid β‐dependent tau phosphorylation is triggered by reactive astrocytes in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077861
- By:
- Publication type:
- Article
Plasma p‐tau231 and p‐tau217 provides information on tau tangle deposition in symptomatic Alzheimer's disease individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076691
- By:
- Publication type:
- Article
GABA transporters gene expression associates with [<sup>18</sup>F]FDG‐PET signal in regions typically hypometabolic in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079619
- By:
- Publication type:
- Article
Association of reactive astrogliosis and microglial activation with tau pathology in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.082041
- By:
- Publication type:
- Article
Association between brain [18F]FDG‐PET signal and genetic cell markers in the brain tissue.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081980
- By:
- Publication type:
- Article
Neuroinflammation Exacerbates Irritability and Agitation in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081973
- By:
- Publication type:
- Article
Astrocyte reactivity is associated with synaptic dysfunction across the aging and Alzheimer's disease spectrum, whereas microglial reactivity is specifically associated with synaptic dysfunction related to cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081975
- By:
- Publication type:
- Article
Synaptic dysfunction in the presence of tau tangles is not a strong predictor of atrophy.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081954
- By:
- Publication type:
- Article
Microglial Activation Contributes to Neuropsychiatric Dysfunction in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081950
- By:
- Publication type:
- Article
Synapse dysfunction and astrocyte reactivity are associated independently of amyloid‐β and tau pathologies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081939
- By:
- Publication type:
- Article
CSF total tau is more closely associated with synaptic dysfunction than overt neurodegeneration.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081943
- By:
- Publication type:
- Article
Potential utility of using both APOEε4 and Aβ positivity to enrich clinical trials of tau‐targeting therapies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081933
- By:
- Publication type:
- Article
GABA transporters gene expression associates with [18F]FDG‐PET signal in regions typically hypometabolic in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081920
- By:
- Publication type:
- Article
APOEε4 potentiates the effects of Aβ pathology on the deposition of neurofibrillary tangles via tau phosphorylation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081925
- By:
- Publication type:
- Article
Microglial activation interacts with amyloid‐β to drive longitudinal tau tangle accumulation and cognitive decline.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081881
- By:
- Publication type:
- Article